Mari Kamiya Selected Research

Mari Kamiya Research Topics

4	Inflammation (Inflammations) 01/2023 - 01/2022
3	Rheumatoid Arthritis 01/2024 - 01/2016
3	Polymyositis 01/2023 - 01/2022
3	Muscle Weakness 01/2023 - 01/2022
2	COVID-19 01/2023 - 01/2021
2	Myositis (Idiopathic Inflammatory Myopathies) 10/2022 - 01/2022
2	Fever (Fevers) 01/2016 - 01/2015
1	Emphysema 12/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2023
1	Communicable Diseases (Infectious Diseases) 01/2023
1	Infections 01/2023
1	Obesity 01/2023
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 04/2022
1	Muscular Atrophy (Muscle Atrophy) 01/2022
1	Hemorrhage 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Acute Tubulointerstitial Nephritis 01/2016
1	Cryoglobulinemia 01/2016
1	Crohn Disease (Crohn's Disease) 01/2016
1	Eosinophilia 01/2016
1	Neurologic Manifestations (Neurological Manifestations) 01/2016
1	Allergic Bronchopulmonary Aspergillosis 01/2016

1	Methotrexate (Mexate)FDA LinkGeneric 01/2024
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023
1	Viral ProteinsIBA 01/2023
1	LigandsIBA 01/2023
1	CytokinesIBA 01/2023
1	LeptinIBA 01/2023
1	HMGB1 Protein (HMG1)IBA 01/2023
1	ametantrone (HAQ)IBA 12/2022
1	AntibodiesIBA 10/2022
1	Granzymes (Granzyme)IBA 10/2022
1	Fas Ligand Protein (Fas Ligand)IBA 10/2022
1	PerforinIBA 10/2022
1	belimumabIBA 04/2022
1	GlucocorticoidsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	Antirheumatic Agents (DMARD)IBA 01/2016
1	Immunoglobulin E (IgE)IBA 01/2016
1	PrecipitinsIBA 01/2016
1	Adalimumab (Humira)FDA Link 01/2016
1	Infliximab (Remicade)FDA Link 01/2016
1	Prednisolone (Predate)FDA LinkGeneric 01/2016
1	C-Reactive ProteinIBA 01/2015

6	Therapeutics 01/2023 - 01/2016